Human-derived glycoprotein, biologically active factor which includes glycoprotein, and pharmaceutical product which comprises biologically active factor as active component
US 6,333,309 Lapsed on the fee recordLapsed Dec 25, 2013 on the fee record · From the USPTO record
20-year base term ended Mar 19, 2016
Third maintenance fee unpaid; grace period ended.
Mar 19, 1996
Dec 25, 2013
Dec 25, 2001
Mar 19, 2016
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 19, 1996, when this application, 08/617,621, was filed | Mar 19, 2016 | USPTO record |
| Continuity chain | Every parent in the chain resolved | no change | USPTO record |
| Patent term adjustment | None on file | no change | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 2 of 3 maintenance fees paid | lapsed Dec 25, 2013 | USPTO record |
| Computed term end | The steps above, in order | Dec 25, 2013 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.